Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. (CRXTQ) Stock Overview
Explore Clarus Therapeutics Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
72.8K
P/E Ratio
-0.00
EPS (TTM)
$-0.47
ROE
0.33%
CRXTQ Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Clarus Therapeutics Holdings, Inc. (CRXTQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 72.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.